MANUFACTURING METHOD OF CONTROLLED-RELEASE TABLET CONTAINING DOXAZOCIN MESYLATE
摘要
<p>The present invention relates to a manufacturing method of the controlled-release tablet comprising doxazocin mesylate. The manufacturing method of the present invention is simple and economical, and can provide the controlled-release tablet that releases doxazocin mesylate at zero-order rate for 12 hours and has reduced content variation and dissolution variation. Therefore, the manufacturing method of the present invention can provide a cost-effective controlled-release tablet comprising doxazocin mesylate that shows its efficacy for a long time, and has reduced in vivo absorption variation.</p>
